Protecting American Innovation Act
Latest action · Apr 6, 2022 Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 6, 2022
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Protecting American Innovation Act
This bill establishes certain limitations on modifying trade agreements, including those related to the TRIPS Agreement (i.e., the Agreement on Trade-Related Aspects of Intellectual Property Rights). The TRIPS Agreement contains obligations for World Trade Organization members to protect patents and other intellectual property rights.
Specifically, the bill prohibits the President (or any U.S. official, employee, or agent) from negotiating or concluding any withdrawal, suspension, or modification to a trade agreement that adversely affects the rights of the United States or U.S. persons under a trade agreement with China or Russia.
Additionally, the bill states that a TRIPS waiver to address the COVID-19 pandemic shall not take effect if (1) the President does not submit required reports from the Department of Commerce and the Department of Defense (DOD), (2) the Commerce report concludes that the TRIPS waiver will not result in an increase in global vaccine access, or (3) the DOD report concludes that the TRIPS waiver would adversely impact U.S. national security.
Prior to entering into a negotiation with a trading partner concerning a suspension of or modification to a trade agreement, the bill requires (1) the U.S. Trade Representative to publish certain information in the Federal Register and allow for public comment, and (2) the President to provide written notice and consult with Congress. Further, the President shall not enter into any suspension of or modification to a trade agreement unless the President has complied with such consultation requirements and receives congressional approval.
Cosponsors 11
Members who signed on, in the order they did. Signatures ran from Apr 6, 2022 to Jun 7, 2022, with 10 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-GA | A. Drew Ferguson IV | Original | Apr 6, 2022 |
| R-OH | Brad R. Wenstrup | Original | Apr 6, 2022 |
| R-WV | Carol D. Miller | Original | Apr 6, 2022 |
| R-IL | Darin LaHood | Original | Apr 6, 2022 |
| R-NC | Gregory F. Murphy | Original | Apr 6, 2022 |
| R-IN | Jackie Walorski | Original | Apr 6, 2022 |
| R-OK | Kevin Hern | Original | Apr 6, 2022 |
| R-PA | Lloyd Smucker | Original | Apr 6, 2022 |
| R-KS | Ron Estes | Original | Apr 6, 2022 |
| R-FL | Vern Buchanan | Original | Apr 6, 2022 |
| R-AZ | David Schweikert | Jun 7, 2022 |
Actions 2
Everything that happened, newest first.
- Apr 6, 2022Introduced in House
- Apr 6, 2022Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3788 | Protecting American Innovation Act | Identical bill | Jun 8, 2021 |
Subjects
Assigned by the Library of Congress. Policy area: Foreign Trade and International Finance.
- Asia
- Cardiovascular and respiratory health
- China
- Competitiveness, trade promotion, trade deficits
- Congressional oversight
- Emergency medical services and trauma care
- Employee performance
- Europe
- Federal officials
- Foreign aid and international relief
- Foreign Trade and International Finance
- Government ethics and transparency, public corruption
- Government information and archives
- Government studies and investigations
- Health care coverage and access
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Intellectual property
- Legislative rules and procedure
- Manufacturing
- Medical research
- Presidents and presidential powers, Vice Presidents
- Public participation and lobbying
- Research and development
- Russia
- Trade agreements and negotiations
- World health
Text 1
Each version as it was printed, newest first.
- Apr 6, 2022Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.